Share the QR code < / P > < p > with wechat scanning code to friends and circle of friends < / P > < p > [guide] & nbsp; The second generation vaccine is to develop new vaccines for the mutant delta strain and beta strain. Now Wuhan Institute and Beijing Institute have developed and prepared such vaccines

China's official account of "WeChat China", September 3rd, September 7th, China International Trade Fair on services was held in Beijing. The two generation of novel coronavirus pneumonia, the world's first approved clinical trial, and the world's first new variant of the new crown mutation vaccine has attracted much attention. p> < p > China Bio is the only bio product enterprise in the world to develop 4 new crown vaccines, 3 diagnostic reagents and 2 therapeutic drugs in the field of new crown anti epidemic < p > how is the progress of new crown specific drugs? What is the second generation new crown vaccine < p > walk into the service trade fair and listen to Zhu Jingjin, Secretary of the Party committee of China biology and global leader of phase III clinical project of Xinguan vaccine < p > the world's first new crown specific drug has been approved for clinical trial < / P > < p > what effect can the world's first new crown specific drug unveiled at the service trade fair produce in treatment? Why is it called a "special drug"

Zhu Jingjin: in terms of treatment, because COVID-19 is a new virus, it has no new drugs and specific drugs at the beginning. According to the experience of SARS, China's rehabilitative plasma therapy is a national treatment for severe and severe diseases. p> < p > based on the preparation of convalescent plasma, CNBC has made specific immunoglobulin, which has completed preclinical research, process validation and animal test. Animal tests showed that the symptoms and injuries caused by COVID-19 infection could be significantly relieved. The clinical approval of the National Drug Administration has just been obtained. p> < p > convalescent plasma has previously entered the national new crown diagnosis and treatment program. At present, it has very good curative effect on critically ill and severe new crown patients

) is a new class of new drugs for the treatment of biological products. Human Immunoglobulin is the first new China crown pneumonia specific drug to be produced by plasma immunization after the use of the new crown inactivated vaccine. It is also another breakthrough in the field of treatment of the new biological research team of the national biological resistance unit of China national drug group, COVID-19 (pH4). p> < p > it is called "specific drug" because it is widely used and takes effect faster. It can be used for emergency treatment of severe patients and high-risk groups, and plays an important role in the current clinical treatment < p > as a drug, specific immunoglobulin must have a very scientific and rigorous process from clinical trial to approval for marketing

China Bio specific Human Immunoglobulin

bio bio Tiantan is a new Wuhan blood research and development special exhibition. China's biological New Coronavirus vaccine is approved by the approved Chinese biological New Coronavirus vaccine. The intravenous specific human immunoglobulin containing high titer sars-cov-2 neutralizing antibody was prepared by virus inactivation and removal

the drug is mainly used for the treatment of New Coronavirus pneumonia COVID-19, specifications for 5000U/ bottles (1.25g, 25ml), 10000U/ bottles (2.5G, 50ml). p> < p > intravenous covid-19 human immunoglobulin (pH4) < / P > < p > on January 30, 2020, China biology took the lead in undertaking the key special project "preparation of specific plasma and specific immunoglobulin for patients in the recovery period of 2019 ncov infection" (Project No. 2020yfc0841800) of the national key R & D plan "public safety and risk prevention and emergency technical equipment" of the Ministry of science and technology. In April 2020, China biotic group, China Bio first took the lead in the plasma treatment of the new crown rehabilitation patients, and developed a special Human Immunoglobulin, a special drug for the treatment of new crown. It was prepared from healthy people plasma after immunization with the recovered plasma or the approved Chinese biological New Coronavirus inactivated vaccine. It contains high titer sars-cov-2 neutralizing antibody. The treatment has been included in the New Coronavirus pneumonia diagnosis and treatment plan. Novel coronavirus pneumonia rehabilitated plasma was first diagnosed in the early stage of p>

2020, and the importance of emergency treatment for critically ill patients has been reached nationwide. China's Micro public welfare, China people.com.cn, China's Chinese Medical Doctor Association, health net, China network, China Central Television, China net, surging news, people's good doctors, official micro-blog, micro public welfare, headlines, micro-blog government, Tencent news, Baidu App, pear TV and other buddy partners jointly launched the donation relay donation micro plasma initiative to new crown pneumonia rehabilitation. p> < p > from plasma therapy to new crown vaccine to new crown specific immunoglobulin, Chinese biology has made major breakthroughs in "diagnosable, treatable and preventable", demonstrating Chinese science and technology, made in China and Chinese strength < p > what is another specific drug that appears at the service trade fair? What is the current progress

Zhu Jingjin: this trade show, another monoclonal antibody we have exhibited, is a monoclonal antibody 2B11 designed by COVID-19, which is developed by China National Pharmaceutical Group. It has high neutralization activity for COVID-19 prototypes and Delta strains. The study of virus attack in animals showed that McAb 2B11 could significantly reduce the weight loss and lung viral load caused by virus infection, and significantly reduce the lung inflammation caused by virus infection. The research results have been published in cell discovery, a subsidiary of nature. At present, we are also actively promoting the start of clinical research < p > the world's first, and the second-generation new crown vaccine for the mutant strain is ready < / P > < p > what is the second-generation new crown vaccine? What is the difference between it and the new generation of coronal vaccine

Zhu Jingjin: the China Bio Pharmaceutical Group, which has Chinese medicine around COVID-19, can be diagnosed, treated and prevented. There are 3 technical routes, 4 vaccines, two inactivated vaccines, a recombinant protein vaccine and a mRNA vaccine. After the two new crown inactivated vaccines went on the market, our scientific and technological research has not stopped, and we are developing new vaccines around the new crown variant strain < p > the second generation vaccine we are talking about is to develop new vaccines against the mutant delta strain and beta strain. Now Wuhan Institute and Beijing Institute have developed and prepared such vaccines < p > there are two second-generation vaccines, one is the recombinant protein new crown vaccine, which is a broad-spectrum recombinant protein new crown vaccine "tailored" for virus variation, and the other is the mRNA new crown vaccine, which is also a new crown vaccine for mutant strains. They are all called the second-generation vaccine. The new generation of coronal vaccine is mainly ?
2023-03-22 10:04:42